Evidence map›Paper›PMID 27398407›Full record

ArticleJCI insight2016

A wearable artificial kidney for patients with end-stage renal disease.

Victor Gura, Matthew B Rivara, Scott Bieber, Raj Munshi, Nancy Colobong Smith, Lori Linke, John Kundzins, Masoud Beizai, Carlos Ezon, Larry Kessler and 1 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in JCI insight, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02280005 nacompletednot on this map

First 24 Hour Human Trial of the Wearable Artificial Kidney

TypeinterventionalSponsorBlood Purification Technologies, Inc.Ran2014 to 2016Enrolled8ConditionsEnd Stage Renal DiseaseArmsWAK Treatment
NCT05887518 nawithdrawnnot on this mapstarted 2023, after this paper: background citation

The Effect of Sock Developed Wıth Wearable Technology for Patıents Undergoıng Transurethral Resectıon Surgery on the Development of Hypothermıa and Venous Thromboembolısm

TypeinterventionalSponsorTarsus UniversityRan2023 to 2024Enrolled0ConditionsTransurethral Resection, Wearable Devices, Venous Thromboembolism, HypothermiaArmsSocks Developed with Wearable Technology
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Review
  10. Article
  11. Artificial kidney: Challenges and opportunities.World journal of transplantation · 2024
    Review
  12. Advances in Human-Centered Care to Address Contemporary Unmet Needs in Chronic Dialysis.International journal of nephrology and renovascular disease · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Advances in hemodialysis therapy.Faculty reviews · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Victor GuraCedars-Sinai Medical Center, Los Angeles, California, USA.
Matthew B RivaraKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
Scott BieberKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
Raj MunshiKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
Nancy Colobong SmithKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
Lori LinkeKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
John KundzinsKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
Masoud BeizaiBlood Purification Technologies Inc., Beverly Hills, California, USA.
Carlos EzonBlood Purification Technologies Inc., Beverly Hills, California, USA.
Larry KesslerKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
Jonathan HimmelfarbKidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington, USA.
University of Washington · USCedars-Sinai Medical Center · USUniversity of Washington Medical Center · US

Funding

RESEARCH TRAINING IN RENAL DISEASET32DK007467 · NIDDK · UNIVERSITY OF WASHINGTON · PI BANSAL, NISHA, KESTENBAUM, BRYAN R · 1986 to 2023
$5.1M
NIDDK NIH HHS T32 DK007467
6 · The paper itself

Abstract

backgroundStationary hemodialysis machines hinder mobility and limit activities of daily life during dialysis treatments. New hemodialysis technologies are needed to improve patient autonomy and enhance quality of life.

methodsWe conducted a FDA-approved human trial of a wearable artificial kidney, a miniaturized, wearable hemodialysis machine, based on dialysate-regenerating sorbent technology. We aimed to determine the efficacy of the wearable artificial kidney in achieving solute, electrolyte, and volume homeostasis in up to 10 subjects over 24 hours.

resultsDuring the study, all subjects remained hemodynamically stable, and there were no serious adverse events. Serum electrolytes and hemoglobin remained stable over the treatment period for all subjects. Fluid removal was consistent with prescribed ultrafiltration rates. Mean blood flow was 42 ± 24 ml/min, and mean dialysate flow was 43 ± 20 ml/min. Mean urea, creatinine, and phosphorus clearances over 24 hours were 17 ± 10, 16 ± 8, and 15 ± 9 ml/min, respectively. Mean β

conclusionTreatment with the wearable artificial kidney was well tolerated and resulted in effective uremic solute clearance and maintenance of electrolyte and fluid homeostasis. These results serve as proof of concept that, after redesign to overcome observed technical problems, a wearable artificial kidney can be developed as a viable novel alternative dialysis technology.

trial registrationClinicalTrials.gov NCT02280005.

fundingThe Wearable Artificial Kidney Foundation and Blood Purification Technologies Inc.

Identifiers

PMID27398407
PMCPMC4936831
OpenAlexW2417175048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.